Диссертация (1141329), страница 18
Текст из файла (страница 18)
Online instruments used in pharmaceuticalmarketing. Farmacia, 2017, Vol. 65, 2.89. Arab Union of the Manufacturers of Pharmaceuticals and Medical Appliances.2011. Available at: www.Aupam.Org (accessed 09.12.2014) (in Arabic).90. Ashur H., AL-Abady I. Direct-to-consumer advertising for pharmaceuticals inJordan from a gender perspective. Eastern Mediterranean Health Journal. Vol.22. № 6.2016. pp. 383–393.91.Chris Paddison, Jonathan Anscombe, Jonathan Plimley, Keith Lostaglio,Michael Thomas. Time for Pharma to Dive into Digital. New Medicine for a New World.2015. Available at: www.atkearney.com/health92. Churchill N., Lewis V.
The Five Stages of Small Business Growth. YarvardBusiness Review. 1983. Vol. 61. №. 3. pp. 30–50.93. Code of ethics for medicinal products promotion in Lebanon and implementationprocedures.MinistryofgeneralhealthLebanon.May,2016.–Availableat: http://www.moph.gov.lb/userfiles/files/HealthCareSystem/Pharmaceuticals/%D9%8FEthics/DrugsEthicalStandards/CodeofEthics2016-Final.pdf.94.David Champagne, Amy Hung, Olivier Leclerc.
The road to digital successin pharma. McKinsey & Company Pharmaceuticals & Medical Products. Аugust 2015.Availableat:https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/the-road-to-digital-success-in-pharma95.Dhara Parekh, Dr. Pankaj Kapupara, Ketan Shah. Digital PharmaceuticalMarketing: A Review. Research Journal of Pharmacy and Technology 9(1):108. January201611896. Directive 2001/83/EC of the European Parliament and of the Council of 6November 2001 on the Community code relating to medicinal products for human use.Available at: http://ec.europa.eu/health/files/eudralex/vol1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf.97.
Dobson A.J., A.G. Barnett. An Introduction to Generalized Linear Models.Chapman and Hall. CRC. Taylor & Francis Group, 2008.98. Donohue J.M., Cevasco M., Rosenthal MB (2007) A decade of direct-toconsumer advertising of prescription drugs. N Engl J Med 357: 673–681.99. DSM Group Фармацевтический рынок России, январь 2016.
Availableat: http://dsm.ru/docs/analytics/january_2016_pharmacy_analysis.pdf.100. Flamholtz E.G. Managing the Transition from an Entrepreneurship to aProfessionally Managed Firm. – San Francisco: Jossey-Bass, 1986.101. Francesca Renee, Dillman Carpentier. Considering the Future ofPharmaceutical Promotions in Social Media. Int J Health Policy Manag. 2016, 5(4), 283–285102. Galbraith J. The Stages of Growth. Journal of Business Strategy.
1982. Vol.3. № 4. pp. 70–79.103.Gilbody S., Wilson P., Watt I. Benefits and harms of direct to consumeradvertising: A systematic review. Qual Saf Health Care. 2005. № 14(4) : 246–250. PMID:16076787.104. Greiner L. Evolution and revolution as oganizations grow. Harvard BusinessReview. 1972. Vol. 50. № 4. pp. 37–46.105.Gummesson, E. Making relationship marketing operational, InternationalJournal of Service Industry Management 5: 5–20.106.IMS Institute for Healthcare Informatics (2011) The Use of Medicines inthe United States: Review of 2010. Available at: www.theimsinsitute.org.107.Instructions number 3 of 2014 about the regulation of medical promotion inPalestine.
Available at: http://muqtafi.birzeit.edu/pg/getleg.asp?id=16687119108. Kazanijian R.K. Relation of Dominant Problems to Stages of Growth inTechnology-Based New Ventures. Academy of Management Journal. 1988. Vol. 31 № 2.pp. 257–279.109. Khateib R.A. The Effect Of Direct Consumer Advertising On ThePurchasing Decisions, Master Degree Of Business Administration, University of MiddleEast, Jordan. 2012. 110 p.110. Kornfield R., Donohue J., Berndt E.R., Alexander G.C. Promotion ofPrescription Drugs to Consumers and Providers, 2001–2010. PLOS ONE 8(3): e55504.Available at: https://doi.org/10.1371/journal.pone.0055504.111. Kotler P.
Megamarketing. Harward Business Review 64:11724.112. Kracov D.A. Davar M. Pharmaceutical advertising USA 2017. InternationalComparative Legal Guide. Available at: https://iclg.com/practice-areas/pharmaceuticaladvertising/pharmaceutical-advertising-2017/usa.113. Lakshmi Thapodhan, Rayudu Gurala, Limitations of digital pharmamarketing. Journal of Direct Data and Digital Marketing Practice. June 2017.
Availableat:https://www.researchgate.net/publication/317836891_LIMITATIONS_OF_DIGITAL_PHARMA_MARKETING114. Law of Medical Professions in Lebanon of 01.08.1994 № 367. Available at:www.opl.org.lb/newdesign/pdf/regulations/367.doc.115. Law of Medical Professions in Syria of 01.07.1970. №. 12. Art. 2, 4, 7.Available at: www.aleppo-doctors.org/files/attachments/law12.doc.116. Law of the system of scientific offices for medical advertising of 30.03.2005.№. 7. Art. 1, 2, 5, 6. Available at: http: //www.casi.gov.sy/node15/ara¬bic/in¬dex.php?No-de = 5518 & cat = 14765 &.117.
Lester D.L., Parnell J.A., Carraher S. Organizational Life Cycle: A Five‐Stage Empirical Scale.The International Journal of Organizational Analysis. 2003. Vol.11, issue 4. pp. 339–354.118. Liang B.A., Mackey T.K. Prevalence and global health implications of socialmedia in direct to-consumer drug advertising. J Med Internet Res. 2001. № 13(3).120119. Lippit G.L.
Schmidt C.C. Organizational Strategy, Structure and Process. N.Y.: McGraw-Hill, 1978.120. Long, J.S. Regression Models for Categorical and Limited DependentVariables. Sage Publications, 1997.121. Mattson L.-G. Relationship marketing and the Markets-as- networksapproach – A comparative analysis of two evolving streams of research.
Journal ofMarketing Management 13:447. P. 61.122. McCarthy, E. Jerome and Shapiro. Basic Marketing, Canadian 3rd edn,Homewood, II.:Richard D. Irwin.123. McCullagh, P. and J.A. Nelder. Generalized Linear Models. New York:Chapman & Hall, 1990.124. Michael Byrnes. How Digital is Shaping the Future of PharmaceuticalMarketing.ManhattanResearch.2009.Availableat:http://www.rx-edge.com/research%20pdfs/How_Digital_is_Shaping_the_Future_of_Pharma_Marketing.pdf.125. Michael S.
Sinha, Aaron S. Kesselheim, Jonathan J. Darrow, PharmaceuticalAdvertising in Medical Journals: Revisiting a Long-Standing Relationship. Chest.JANUARY 2018.126. Miller D. Friesen P.H. A Longitudinal Study of the Corporate Life Cycle.Management Science. 1984. Vol. 30, issue 10. pp. 1161–1183.127. Miller D., Friesen P.Н. Successful and Unsuccessful Phases of the Corporatelife Cycle. Organization Studies.
1983. Vol. 4. № 4. pp. 339–357.128. Morgan S.G. Direct-to-consumer advertising and expenditures onprescription drugs: A comparison of experiences in the United States and Canada. – OpenMed, 2007;1(1):e37–e45.129. MultinomialModelsforNominalResponses.–Availableat:https://www.mathworks.com/help/stats/multinomial-models-for-nominal-responses.html.130. Nasser M.J., Hammoud A.M. The Role of the Promotion Policies inMarketing Syrian Drug Products (A Field Study of Syrian Drug Companies). Tishreen121University Journal for Studies and Scientific Research- Economic and Legal ScienceSeries. Vol.
28. № 2. 2006. pp. 155–174.131. Nelson R. When ads trump evidence: Is direct-to-consumer advertisingleading practice? Am J Nurs 2007;107(10):25–26.132. Nikhil Mohanan, Meenal Kulkarni. A study to evaluate the role of digitalmarketing on consumer buying behavior of over the counter (OTC) pharmaceuticalproducts. International Journal of Pharma and Bio Sciences 2018 April ; 9(2): (P) 8-16133. Pricesformedicinesin2013.–Availableat:in2015/–Availableat:http://syriadailynews.com/17130.134.
Pricesformedicineshttps://www.dropbox.com/s/g91d6xzugo7pm61/الجديدة20%االسعار20% نشرة-2017%بتاريخ20%2015-8.xlsx?dl=0.135. Prices for medicines in 2017/ – Available at: http://www.dampharmacy.com/Articles/Details?num=6330.136. Quinn R.E., Cameron K. Organizational Life Cycles and Shifting Criteria ofEffectiveness: Some Preliminary Evidence. Management Science.
1983. Vol. 29. № 1.pp. 33–51.137. Robin Робинсон. Where Have All The Sales Reps Gone? / PharmaVOICE–January2015.–Availableat:http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0055504.138. Rosenthal M.B., Berndt E.R., Donohue J.M., Frank R.G., Epstein A.M.Promotion of prescription drugs to consumers.
N Engl J Med 346: 498–505.139. Schein E.H. Organization culture and leadership. San-Francisco: Jossey-Bass,1985.140. Scott B.R., Bruce R. Five Stages of Growth in Small Business. Long RangePlanning. 1987. Vol. 20. № 3. pp. 45–52.141. Silversides A. Abramson: Direct-to-consumer advertising willerode healthcare. Can Med Assoc J 2008;178(9):1126–1127.122142. Smith K.G., Mitchell T.R., Summer C.E.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
